Member Directory
Member Directory

Pfizer Wins 2d Trial in Zoloft Birth Defect Case

em>From Reuters

A jury in Philadelphia ruled that Pfizer Inc. properly warned about the risks that its Zoloft antidepressant could cause birth defects and isn’t responsible for a girl’s heart abnormalities. It is the drugmaker’s second win in cases over the medication.

The Philadelphia jury rejected Mia Robinson’s claims that Pfizer officials hid Zoloft’s birth-defect risks and should pay at least $2.4 million to compensate the eight-year-old girl for her heart abnormalities.

The company persuaded a St. Louis jury in April to reject a family’s arguments that the drug caused a boy’s cardiac abnormalities in the first of more than 1,000 lawsuits over the medication to go to trial.

Zoloft is best-selling antidepressant on the market.

The case is Robinson v. Wolters Kluwer Health Inc., July Term, 2011, No. 778, Control No. 14123047, Pennsylvania Court of Common Pleas of Philadelphia County (Philadelphia).

Find an Attorney

The National Trial Lawyers stands as an esteemed, exclusive association comprising top-tier trial attorneys nationwide. Whether you require a Civil Plaintiff Lawyer or a Criminal Defense Lawyer in your state, our network ensures access to premier legal expertise tailored to your needs.
Find Attorney

Read More Legal News

© Copyright 2022, All Rights Reserved | National Trial Lawyers
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram